Insights

Gathering insights about NGN…

Similar companies to NGN

Tech Connectors
$1M$10M

NGN Tech Stack

NGN uses 8 technology products and services including Facebook Pixel, iCIMS, Cloudflare, and more. Explore NGN's tech stack below.

Facebook Pixel
Analytics
iCIMS
Applicant Tracking Systems
Cloudflare
Content Management System
MySQL
Database
Windows Server
Operating Systems
PHP
Programming Languages
Bootstrap
UI Frameworks
Twitter
Widgets

Media & News

Neurogene Announces Successful Completion of Dosing in Embolden™ Registrational Trial of NGN-401 for Rett Syndrome
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological
Jun 08, 2026 | www.gurufocus.com
Neurogene Announces Successful Completion of Dosing in Embolden™ Registrational Trial of NGN-401 for Rett Syndrome
NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced the successful completion of dosing in the Embolden™ registrational trial of NGN-401, an investigational gene therapy designed to be a potential best-in-class, one-time treatment for Rett syndrome. While the initial enrollment target was 20 participants, the statistical analysis plan p.
Jun 08, 2026 | www.businesswire.com
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the Compensation Committee of the Company's Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 17,045 shares of the Company's common stock to two new employees (the “Inducement Grants”) on June 1, 2026 (the “Grant Date”). The Inducemen.
Jun 02, 2026 | www.businesswire.com
Neurogene Reports First Quarter 2026 Financial Results and Highlights Recent Updates
NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced first quarter 2026 financial results and highlighted recent corporate updates. “The significant unmet need in Rett syndrome and strong interest among physicians and caregivers continue to drive momentum for NGN-401, with approximately 90% of participants dosed in the Embolden™ registra.
May 12, 2026 | www.businesswire.com
Neurogene Highlights Data at ASGCT Meeting Supporting Therapeutic Rationale for ICV Delivery Method in CNS-targeted Gene Therapy
NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, highlighted data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting supporting the intracerebroventricular (ICV) route of administration as a routine approach for delivering medicines, including gene therapies, to treat central nervous system (CNS) disorders. The presentation furt.
May 12, 2026 | www.businesswire.com
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the Compensation Committee of the Company's Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 122,565 shares of the Company's common stock to two new employees (the “Inducement Grants”) on May 5, 2026 (the “Grant Date”), including an.
May 06, 2026 | www.businesswire.com
Neurogene Announces Upcoming Presentation on the Therapeutic Rationale for ICV Delivery in CNS-Targeted Gene Therapy
NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced an upcoming poster presentation that will demystify the intracerebroventricular (ICV) route of administration as a well-established, routinely performed neurosurgical procedure and a deliberate delivery strategy designed to maximize efficacy for central nervous system (CNS) gene therap.
Apr 28, 2026 | www.businesswire.com

NGN's Email Address Formats

NGN uses at least 1 format(s):

NGN Email Formats	Example	Percentage
FLast@ngn.com.tr	JDoe@ngn.com.tr	99%
FL@ngn.com.tr	JD@ngn.com.tr	1%

Frequently Asked Questions

Where is NGN's headquarters located?

NGN's main headquarters is located at no 127 Büyükdere Cad. Kule Kat 1 Esentepe, Istanbul Turkey. The company has employees across 5 continents, including AsiaEuropeNorth America.

What is NGN's stock symbol?

NGN is a publicly traded company; the company's stock symbol is NGNE.

What is NGN's official website and social media links?

NGN's official website is ngn.com.tr and has social profiles on LinkedIn.

What is NGN's NAICS code?

NGN's NAICS code is 5415 - Computer Systems Design and Related Services.

How many employees does NGN have currently?

As of May 2026, NGN has approximately 320 employees across 5 continents, including AsiaEuropeNorth America. Key team members include Ceo Asistanı: A. Ç. K.Cfo: O. H.Head Of Dc Bu: S. G.. Explore NGN's employee directory with LeadIQ.

What industry does NGN belong to?

NGN operates in the IT Services and IT Consulting industry.

What technology does NGN use?

NGN's tech stack includes Facebook PixeliCIMSCloudflareMySQLWindows ServerPHPBootstrapTwitter.

What is NGN's email format?

NGN's email format typically follows the pattern of FLast@ngn.com.tr. Find more NGN email formats with LeadIQ.

When was NGN founded?

NGN was founded in 2005.

NGN

Q: What is NGN's official website and social media links?

NGN's official website is ngn.com.tr. NGN has social profiles on LinkedIn.

Q: How many employees does NGN have currently?

NGN has approximately 320 employees.

Q: What technology does NGN use?

NGN's tech stack includes Cloudflare, Twemoji, Windows Server, reCAPTCHA, Google Analytics.

Q: What is NGN's NAICS code?

NGN's NAICS code is 5415 (Computer Systems Design and Related Services).

IT Services and IT ConsultingIstanbul, Turkey201-500 Employees

NGN is an IT services and consulting firm based in Istanbul, Turkey, with about 20 years in operation. It provides end-to-end professional IT solutions to address a wide range of informatics needs. The company manages clients' IT operations through offerings that include system integration, a domestic data center called Star of Bosphorus, NGN Cloud services, managed and outsourcing services, and digital transformation initiatives.

NGN is recognized as a top performing IT company in Turkey and is positioned as a leading system integrator in data backup and storage. It emphasizes helping customers integrate future-oriented technologies into their business processes and pursues investments intended to add value to Turkey's IT sector and the broader economy.